Haleon TUMS Antacid Recall Issued for Metallic Particles
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Guardian Drug Co. Inc. is recalling specific lots of Haleon TUMS Antacid tablets due to the presence of small metallic particles.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on July 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Guardian Drug Co. Inc. initiated a voluntary recall of Haleon Calcium Carbonate TUMS Antacid due to the presence of foreign substance: small metallic particles in chewable tablets.
Which Products Are Affected
HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 1000 mg, 160-count bottle, Haleon, Warren, NJ 07059, UPC 3 07660 74610 2. Affected lots: 1096075, 1096076, 1096077, 1096078, Exp 1/31/2029. Distributed nationwide in the United States.
What You Should Do
Consumers should verify lot numbers on purchased bottles against the affected codes listed in the recall.
Why This Matters
This Class II recall affects TUMS antacid tablets distributed across the U.S. due to potential foreign material contamination.
Source
FDA recall number D-0558-2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (864 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to July 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.